NAD+ prevents chronic kidney disease by activating renal tubular metabolism
Chronic kidney disease (CKD) is associated with renal metabolic disturbances, including impaired fatty acid oxidation (FAO). Nicotinamide adenine dinucleotide (NAD+) is a small molecule that participates in hundreds of metabolism-related reactions. NAD+ levels are decreased in CKD, and NAD+ suppleme...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
American Society for Clinical investigation
2025-03-01
|
| Schriftenreihe: | JCI Insight |
| Schlagworte: | |
| Online-Zugang: | https://doi.org/10.1172/jci.insight.181443 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|